Phase I Study of HL-085 in Patients With Advanced Solid Tumors

Condition:   Solid Tumor, Adult Intervention:   Drug: HL-085 Sponsor:   Shanghai Kechow Pharma, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials